GENinCode plc (GENI) ORD GBP0.01

Sell:3.20pBuy:4.00pNo change

Prices delayed by at least 15 minutes
Sell:3.20p
Buy:4.00p
Change:No change
Deal now
Prices delayed by at least 15 minutes
Sell:3.20p
Buy:4.00p
Change:No change
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

GENinCode Plc is a United Kingdom-based predictive genetics company focused on the prevention of cardiovascular disease and ovarian cancer. The Company operates business units in the United Kingdom, Europe through GENinCode S.L.U, and in the United States through GENinCode U.S. Inc. Its predictive technology provides patients and physicians with preventive care and treatment strategies. GENinCode invitro-diagnostic molecular tests combine clinical algorithms and AI bioinformatics to advance patient risk assessment to prevent the onset of cardiovascular disease and ovarian cancer. Its testing products include CARDIO inCode Score, LIPID inCode, SUDD inCode, THROMBO inCode, and ROCA Test. Its SITAB is an online Web portal, which provides health care practitioners with a systemized approach to request, record, process and report their clinical and genetic test results. Its CARDIO inCode Score is a genetic test for the evaluation of the coronary genetic load based on a polygenic risk score.

Key people

Matthew Walls
Chief Executive Officer, Executive Director
Paul Foulger
Chief Financial Officer, Executive Director, Company Secretary
Jordi Puig Gilberte
Chief Operating Officer, Executive Director
William Rhodes
Independent Non-Executive Chairman of the Board
Felix Frueh
Independent Non-Executive Director
Huon Gray
Independent Non-Executive Director
Sergio Olivero
Independent Non-Executive Director
Click to see more

Key facts

  • EPIC
    GENI
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB00BL97B504
  • Market cap
    £10.33m
  • Employees
    36
  • Shares in issue
    286.88m
  • Exchange
    London Stock Exchange (LON)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.